ATE403422T1 - Substituierte hydrazone als hemmer von cyclooxygenase-2 - Google Patents
Substituierte hydrazone als hemmer von cyclooxygenase-2Info
- Publication number
- ATE403422T1 ATE403422T1 AT02786980T AT02786980T ATE403422T1 AT E403422 T1 ATE403422 T1 AT E403422T1 AT 02786980 T AT02786980 T AT 02786980T AT 02786980 T AT02786980 T AT 02786980T AT E403422 T1 ATE403422 T1 AT E403422T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclooxygenase
- inhibitor
- substituted hydrazone
- sup
- hydrazone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/48—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom
- C07C311/49—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups having nitrogen atoms of sulfonamide groups further bound to another hetero atom to nitrogen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US33892701P | 2001-12-10 | 2001-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE403422T1 true ATE403422T1 (de) | 2008-08-15 |
Family
ID=23326724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02786980T ATE403422T1 (de) | 2001-12-10 | 2002-12-10 | Substituierte hydrazone als hemmer von cyclooxygenase-2 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7122571B2 (de) |
EP (1) | EP1476149B1 (de) |
JP (1) | JP2005513046A (de) |
AT (1) | ATE403422T1 (de) |
AU (1) | AU2002351331A1 (de) |
CA (1) | CA2469709A1 (de) |
DE (1) | DE60228134D1 (de) |
WO (1) | WO2003049698A2 (de) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005115992A1 (en) * | 2004-05-23 | 2005-12-08 | Housey Pharmaceuticals, Inc. | Theramutein modulators |
EP1791818A1 (de) * | 2004-09-14 | 2007-06-06 | The Genetics Company, Inc. | Hydrazonderivate und ihre verwendung als beta-sekretasehemmer |
US8431110B2 (en) | 2005-05-23 | 2013-04-30 | Hmi Medical Innovations, Llc. | Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators |
CN101541348A (zh) * | 2005-11-03 | 2009-09-23 | 红点生物公司 | 腙衍生物及其用途 |
CA2631182C (en) * | 2005-11-23 | 2019-08-06 | Gerard M. Housey | Compounds and methods of identifying, synthesizing, optimizing and profiling protein modulators |
RU2009131697A (ru) | 2007-02-02 | 2011-03-10 | Рэдпойнт Био Корпорэйшн (Us) | Применение ингибитора trpm5 для регулирования секреции инсулина и гпп-1 |
CN110511197B (zh) * | 2019-08-09 | 2021-03-23 | 华南师范大学 | 一种n-呋喃酮基芳基磺酰腙类化合物及其合成方法和应用 |
CN110590616B (zh) * | 2019-09-02 | 2022-06-21 | 绍兴文理学院 | 一种磺酰腙衍生物及其制备方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1770773A1 (de) * | 1968-07-02 | 1971-12-09 | Henkel & Cie Gmbh | Optisches Aufhellungsmittel |
JPS5545657A (en) * | 1978-09-28 | 1980-03-31 | Rikagaku Kenkyusho | Carcinostatic agent |
FR2528844A1 (fr) * | 1982-06-18 | 1983-12-23 | Chauvin Blache Lab | Nouvelles thiazolyl-2 hydrazones, leur procede de preparation et leur application en therapeutique |
US4732904A (en) * | 1984-12-24 | 1988-03-22 | Morgan Lee R | Antiestrogenic hydrazones |
DE3903990A1 (de) | 1989-02-10 | 1990-08-30 | Basf Ag | Phenylhydrazone, ihre herstellung und daraus hergestellte arzneimittel und kosmetika |
GB9402688D0 (en) | 1994-02-11 | 1994-04-06 | Merck Sharp & Dohme | Therapeutic agents |
ES2105959B1 (es) * | 1995-01-17 | 1998-07-01 | Zeneca Pharma Sa | Derivados de 1,4-dioxido de quinoxalina, procedimiento de preparacion y de utilizacion. |
-
2002
- 2002-12-10 WO PCT/US2002/039343 patent/WO2003049698A2/en active Application Filing
- 2002-12-10 DE DE60228134T patent/DE60228134D1/de not_active Expired - Fee Related
- 2002-12-10 AU AU2002351331A patent/AU2002351331A1/en not_active Abandoned
- 2002-12-10 EP EP02786980A patent/EP1476149B1/de not_active Expired - Lifetime
- 2002-12-10 CA CA002469709A patent/CA2469709A1/en not_active Abandoned
- 2002-12-10 US US10/315,494 patent/US7122571B2/en not_active Expired - Fee Related
- 2002-12-10 AT AT02786980T patent/ATE403422T1/de not_active IP Right Cessation
- 2002-12-10 JP JP2003550749A patent/JP2005513046A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
US7122571B2 (en) | 2006-10-17 |
JP2005513046A (ja) | 2005-05-12 |
EP1476149A2 (de) | 2004-11-17 |
WO2003049698A2 (en) | 2003-06-19 |
DE60228134D1 (de) | 2008-09-18 |
WO2003049698A3 (en) | 2003-08-28 |
EP1476149A4 (de) | 2005-09-14 |
EP1476149B1 (de) | 2008-08-06 |
CA2469709A1 (en) | 2003-06-19 |
WO2003049698A8 (en) | 2004-09-02 |
AU2002351331A1 (en) | 2003-06-23 |
US20030187035A1 (en) | 2003-10-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60311662D1 (en) | 3-hydroxy-6-phenylphenanthridine als pde-4 inhibitoren | |
DE60310576D1 (en) | 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer | |
DE60313472D1 (de) | Pyrrolidindion-substituierte piperidin-phthalazone als pde4-inhibitoren | |
CY1110498T1 (el) | Παραγωγα πυραζολης ως αναστολεις των κινασων τυροσινης υποδοχεα | |
DK1070056T3 (da) | Phthalazinon-PDE III/IV-inhibitorer | |
EA200301100A1 (ru) | Новые фталазиноны | |
ATE228111T1 (de) | M-amidinophenyl-analoga als faktor-xa-inhibitoren | |
RS53629B1 (en) | CYAN ANTHRANYLAMIDE INSECTICIDES | |
DE60112306D1 (de) | Kondensierte pyrazindionderivate als pde5 inhibitore | |
ATE303384T1 (de) | 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren | |
ATE354622T1 (de) | Flüssigkristallines medium | |
SE0103710D0 (sv) | Compounds | |
ATE245642T1 (de) | Benzamide mit tetrahydrofuranyloxy-substituenten als inhibitoren der phosphodiesterase 4 | |
ATE399168T1 (de) | Imidazopyridin-derivate und ihre verwendung als induzierbare no-synthase inhibitoren | |
ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
ATE403422T1 (de) | Substituierte hydrazone als hemmer von cyclooxygenase-2 | |
DE60033809D1 (de) | Inhibitoren von metalloproteinasen | |
SE9903290D0 (sv) | Novel compounds | |
DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
DE602004005016D1 (de) | Biphenylcarboxamidderivate und ihre verwendung als p38 kinase inhibitoren | |
EA200301101A1 (ru) | Производные пиперазина и их применение в качестве ингибиторов pde4 | |
EA200600601A1 (ru) | Производные аминопиридина в качестве ингибиторов индуцируемой no-синтазы | |
DE60122559D1 (de) | Indolderivate als pde5-inhibitoren | |
DE602004015628D1 (de) | Imidazopyridinderivate als induzierbare no-synthaseinhibitoren | |
ATE399169T1 (de) | Imidazopyridinderivate als inhibitoren der induzierbaren no-synthase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |